With seed stage US Venture Capital on the decline and the cost of developing new technology increasingly scrutinized, business development teams in large medical device companies look to reduce risk with staged, milestone-based strategic investments. CTIG’s MPG approach reduces R&D risks and encourages investments in small amounts, providing access to important ancillary products and creating a better overall acquisition environment.

CTIG’s clinical need-focused business model allows us to actively seek out new technology to address the clinical gaps that exist in Obesity, Cardiovascular surgery, Orthopedic, Metabolic Disorders, Wound Care, and Ophthalmology. Our goal is to generate innovative products that provide medical device companies with the opportunity to fit their current distribution and balance sheets while adding to top line growth and profitability.

We rigorously analyze new technology opportunities using a special vetting approach. We then implement our investment/development process, which spans technical feasibility and regulatory requirements to fundraising and first-in-man studies. Once we take on a new project, our proven process has the potential to deliver consistent greater and reproducible returns on investment.


Tenon Medical is developing a minimally invasive approach to treat lower back pain originating in the sacroiliac (SI) joint. The proprietary system consists of the Catamaran implant and a surgical delivery tool.

The SI joint is an underappreciated cause of low back pain. It is more common in presence of trauma, pregnancy, or certain athletes. Back pain may be decreased or eliminated through stabilization or fusion of certain skeletal joints of the body, such as the SI joint of the spine.

Americans spend $50 billion a year on lower back pain. Lumbar pain is the most common cause of job related disability and a leading contributor to missed work. In the US, lower back pain is the number one reason for individuals under the age of 45 to limit activity. Lower back pain is the second most prevalent complaint seen in physician offices and the third leading cause of surgery.

Leading orthopedic publications state that anywhere from 15% to 25% of all lower back pain originates from the SI joint. There is also a group of female post pregnancy patients with problems and instability related to SI joint pathology that could be treated with fusion. Important soft tissue structures, such as ligaments, vessels, and nerves surround the SI joint, making intervention challenging.

The Catamaran addresses this unmet clinical need by providing a less invasive way to stabilize the SI joint without compromising the important surrounding soft tissue structures.